wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q37519804-B49A8C82-F96D-4DD5-8131-3A564B9027A5
Q37519804-B49A8C82-F96D-4DD5-8131-3A564B9027A5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37519804-B49A8C82-F96D-4DD5-8131-3A564B9027A5
Plasma Efavirenz Exposure, Sex, and Age Predict Virological Response in HIV-Infected African Children.
P2860
Q37519804-B49A8C82-F96D-4DD5-8131-3A564B9027A5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37519804-B49A8C82-F96D-4DD5-8131-3A564B9027A5
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
4b754912112915cbb4f0359b7946d21f20515baf
P2860
Efficacy and safety of efavirenz 400 mg daily versus 600 mg daily: 96-week data from the randomised, double-blind, placebo-controlled, non-inferiority ENCORE1 study.